Substance / Medication

Magnesium trisilicate

Overview

Active Ingredient
magnesium trisilicate
RxNorm CUI
29170

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
The Role of Micronutrients in the Pathogenesis of Alcohol-Related Liver Disease.
Nicoll Ruairidh, Gerasimidis Konstantinos, Forrest Ewan · Alcohol Alcohol · 2022
PMID: 34491307Meta-Analysis
Associations Between Serum Magnesium Concentrations and Polycystic Ovary Syndrome Status: a Systematic Review and Meta-analysis.
Babapour Maedeh, Mohammadi Hamed, Kazemi Maryam et al. · Biol Trace Elem Res · 2021
PMID: 32812171Meta-Analysis
What factors predict length of stay in the intensive care unit? Systematic review and meta-analysis.
Peres Igor Tona, Hamacher Silvio, Oliveira Fernando Luiz Cyrino et al. · J Crit Care · 2020
PMID: 32841815Meta-Analysis
Magnesium status and attention deficit hyperactivity disorder (ADHD): A meta-analysis.
Effatpanah Mohammad, Rezaei Mahdi, Effatpanah Hosein et al. · Psychiatry Res · 2019
PMID: 30807974Meta-Analysis
Proton pump inhibitors and hypomagnesemia: A meta-analysis of observational studies.
Srinutta Thawin, Chewcharat Api, Takkavatakarn Kullaya et al. · Medicine (Baltimore) · 2019
PMID: 31689852Meta-AnalysisFull text (PMC)
Measurement uncertainty assessment of magnesium trisilicate column for determination of Sudan colorants in food by HPLC using C8 column.
Chen Ying, He Chao, Cheng Jing-Jun et al. · J Huazhong Univ Sci Technolog Med Sci · 2016
PMID: 27752895Other
Spray dried glyceryl monooleate-magnesium trisilicate dry powder as cubic phase precursor.
Shah Manish H, Biradar Shailesh V, Paradkar Anant R · Int J Pharm · 2006
PMID: 16846704Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Magnesium trisilicate (substance)
SNOMED CT
387117008
UMLS CUI
C0065533
RxNorm CUI
29170

Clinical Data

This intervention maps to 3 entities in the Healos knowledge graph.

3
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.